Tracey Sacco
Corporate Officer/Principal bij SCHOLAR ROCK HOLDING CORPORATION
Vermogen: - $ op 30-04-2024
Actieve functies van Tracey Sacco
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Corporate Officer/Principal | 06-02-2023 | - |
Loopbaan van Tracey Sacco
Eerdere bekende functies van Tracey Sacco
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ACCELERON PHARMA INC. | Verkoop & Marketing | 01-01-2012 | 01-09-2021 |
Opleiding van Tracey Sacco
| Boston College | Undergraduate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Statistieken
Internationaal
| Verenigde Staten | 5 |
Operationeel
| Sales & Marketing | 1 |
| Undergraduate Degree | 1 |
| Masters Business Admin | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Acceleron Pharma, Inc.
 Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Tracey Sacco
- Ervaring
